Cleared Traditional

K974075 - ACCESS TROPONIN I REAGENTS ON THE ACCES...

K974075 is an FDA 510(k) clearance for ACCESS TROPONIN I REAGENTS ON THE ACCES..., manufactured by Beckman Instruments, Inc.. The device is a Class 2 Chemistry device with product code MMI cleared through the Traditional 510(k) pathway after a 12-day FDA review.

K974075 · Beckman Instruments, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1997
Decision
12d
Days
Class 2
Risk

K974075 is an FDA 510(k) clearance for the ACCESS TROPONIN I REAGENTS ON THE ACCESS IMMUNOASSAY ANALYZER. Classified as Immunoassay Method, Troponin Subunit (product code MMI), Class II - Special Controls.

Submitted by Beckman Instruments, Inc. (Chaska, US). The FDA issued a Cleared decision on November 10, 1997 after a review of 12 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Beckman Instruments, Inc. devices

FDA 510(k) Submission Details - K974075

510(k) Number K974075 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 29, 1997
Decision Date November 10, 1997
Days to Decision 12 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 88d · This submission: 12d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MMI Device Classification - Class 2, Special Controls

Product Code MMI Immunoassay Method, Troponin Subunit
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - MMI Immunoassay Method, Troponin Subunit

All 71
Devices cleared under the same product code (MMI) and FDA review panel - the closest regulatory comparables to K974075.
ABL555 BLOOD GAS, ELECTROLYTE & METABOLITE SYSTEM
K974818 · Radiometer America, Inc. · Jan 1998
TROPONIN I ASSAY FOR THE BAYER IMMUNO 1 SYSTEM
K973616 · Bayer Corp. · Dec 1997
ABBOTT AXSYM TROPONIN-I
K974103 · Abbott Laboratories · Nov 1997
TARGET CARDIAC TROPONIN I TEST
K972094 · Texas Immunology, Inc. · Jul 1997
CARDIAC T TROPONIN T RAPID ASSAY
K964372 · Boehringer Mannheim Corp. · Feb 1997
TROPONIN-I TEST SYSTEM
K964862 · Dade Intl., Inc. · Feb 1997